Stockreport

Compass Therapeutics (CMPX) Is Up 17.2% After Analyst Highlights Pipeline Progress and Anticipated Tovecimig Data – Has the Bull Case Changed? [Yahoo! Finance]

Compass Therapeutics, Inc.  (CMPX) 
PDF On November 10, 2025, H.C. Wainwright reiterated its positive view on Compass Therapeutics, highlighting encouraging preclinical progress for CTX-10726 and reporting fav [Read more]